Google
VOR 株価分析 — Vor Biopharma Inc (Healthcare >> Biotechnology)
VOR に関するよくある質問
VORのPER（株価収益率）は？
Vor Biopharma Inc（VOR）は現在PER 0.67倍で取引されています。
VORのROE（自己資本利益率）は？
Vor Biopharma IncのROEは587.06%です。
VORの配当利回りは？
Vor Biopharma Incの配当利回りは0.00%です。
VORの品質スコア（Quality Score）は？
当社のAIはVORの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
VORは今が買い時ですか？
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
VORはどのセクターに属しますか？
Vor Biopharma IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）
VOR AI Analysis Summary
Our AI summary for VOR: Vor Biopharma Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.67, ROE of 587.06%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 21.41
Price
0.26
(1.23%)
Day Change
|
|
|---|
VOR, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 21.41 |
| PBV / Sector |
-7.62 / 44,219.29
|
| Earning Per Share | -16.50 |
| PE / Sector |
0.67 / 19.28
GREAT
|
| PEG or PE/Growth / Sector |
0.03 / 1.23
GREAT
|
| Average 1M Daily Value |
20.81 M
GREAT
|
| Average 1W Daily Value |
18.30 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-04 08:02:21 |
| Symbol | VOR |
| Name | VOR BIOPHARMA INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 54.19 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,146.03 / 9,645.64 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 500 Boylston Street, Boston, MA, United States, 02116
Phone: 617 655 6580
Website: https://www.vorbio.com
Employees: 76
Sector: Healthcare >> Biotechnology
Description: Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
